A Study to Evaluate the Effects of SB-751689 or rhPTH(1-34) on Excretion of Calcium and Phosphate in Women
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
SB-751689 may alter calcium and phosphate handling at the kidney level. This study will
examine what happens to calcium and phosphate, and other electrolytes, at the kidney after
treatment with SB-751689 for 1 month. Another group of subjects will get another drug called
Forteo for 1 month to compare the response of the kidney for calcium and phosphate.